{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:09:41Z","timestamp":1788170981640,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the General Program of Natural Science Foundation of Fujian Province","award":["2023J011179"],"award-info":[{"award-number":["2023J011179"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This study aimed to identify the incidence, risk factors, and outcomes of permanent pacemaker (PPM) implantation after transcatheter aortic valve implantation (TAVI) procedures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective analysis was conducted on 70 patients who underwent TAVI at the Department of Cardiology, Fujian Provincial Hospital, from January 2018 to March 2022. Based on whether a new PPM was implanted after TAVI, all patients were divided into two groups: NEW PPM and NO PPM. Baseline characteristics and clinical data were compared between the two groups. Univariate analysis was used to analyze different variables between the two groups. A binary logistic regression analysis was used to evaluate independent correlates for PPM implantation after TAVI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean age of the 70 patients was 73.1\u2009\u00b1\u20098.8 years. The incidence of PPM implantation was 17.1%. Patients with diabetes and chronic kidney disease were more likely to require PPM (50% vs. 20.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.042, 25% vs. 5.2%, <jats:italic>p<\/jats:italic>\u2009=\u20090.042). Our study did not identify any significant differences in the incidence of electrocardiographic conduction disturbances except for the previous right bundle branch block (RBBB) (NO PPM 6.9% vs. NEW PPM 33.3%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). We found that prosthesis size, implantation depth, procedural duration, and length of hospital and intensive care unit (ICU) stays were comparable between the two groups. The leading independent predictors of PPM implantation were previous RBBB (odds ratio 10.129, <jats:italic>p<\/jats:italic>\u2009=\u20090.034).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The previous RBBB was the leading independent predictor of PPM implantation. New PPM was not associated with significantly new-onset left BBB, extended post-procedure hospitalization, ICU stay, or procedural duration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12872-024-04101-9","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T05:02:20Z","timestamp":1724475740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve implantation"],"prefix":"10.1186","volume":"24","author":[{"given":"Bing-Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Da","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"issue":"9","key":"4101_CR1","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jacc.2020.12.052","volume":"77","author":"MB Leon","year":"2021","unstructured":"Leon MB, Mack MJ, Hahn RT, et al. Outcomes 2 years after transcatheter aortic valve replacement in patients at Low Surgical Risk[J]. J Am Coll Cardiol. 2021;77(9):1149\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"4101_CR2","doi-asserted-by":"crossref","unstructured":"Chamandi C, Barbanti M, Munoz-Garcia A et al. Long-term outcomes in patients with New-Onset Persistent Left Bundle Branch Block following TAVR[J]. JACC Cardiovascular Interventions. 2019;12(12).","DOI":"10.1016\/j.jcin.2019.03.025"},{"issue":"5","key":"4101_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.21037\/acs.2017.07.01","volume":"6","author":"S Arora","year":"2017","unstructured":"Arora S, Vavalle JP. Transcatheter aortic valve replacement in intermediate and low risk patients - clinical evidence[J]. Annals Cardiothorac Surg. 2017;6(5):493.","journal-title":"Annals Cardiothorac Surg"},{"issue":"1","key":"4101_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7326\/0003-4819-158-1-201301010-00007","volume":"158","author":"PJ Khatri","year":"2013","unstructured":"Khatri PJ, Webb JG, Rod\u00e9s-Cabau J, et al. Adverse effects Associated with transcatheter aortic valve Implantation[J]. Ann Intern Med. 2013;158(1):35.","journal-title":"Ann Intern Med"},{"issue":"1","key":"4101_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jcin.2014.07.022","volume":"8","author":"TM Nazif","year":"2015","unstructured":"Nazif TM, Dizon J, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER valves) trial and registry.[J]. Jacc Cardiovasc Interventions. 2015;8(1):60\u20139.","journal-title":"Jacc Cardiovasc Interventions"},{"key":"4101_CR6","doi-asserted-by":"crossref","unstructured":"Ando T, Takagi H, Telila T et al. Comparison of outcomes in new-generation versus early-generation heart valve in transcatheter aortic valve implantation: a systematic review and meta-analysis[J]. Cardiovascular Revascularization Medicine: Including Mol Interventions. 2017;19(2).","DOI":"10.1016\/j.carrev.2017.07.006"},{"issue":"1","key":"4101_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000502792","volume":"145","author":"F Du","year":"2020","unstructured":"Du F, Zhu Q, Jiang J, Chen H, Liu X, Wang J. Incidence and predictors of permanent pacemaker implantation in patients who underwent transcatheter aortic valve replacement: Observation of a Chinese Population. Cardiology. 2020;145(1):27\u201334.","journal-title":"Cardiology"},{"key":"4101_CR8","doi-asserted-by":"publisher","first-page":"743257","DOI":"10.3389\/fcvm.2021.743257","volume":"8","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chi C, Tian S, Zhang S, Liu J. Predictors of permanent pacemaker implantation in patients after transcatheter aortic valve replacement in a Chinese Population. Front Cardiovasc Med. 2022;8:743257.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"4101_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1540-8167.2011.02211.x","volume":"23","author":"D Erkapic","year":"2012","unstructured":"Erkapic D, De Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23(4):391\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"4101_CR10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/ccd.24713","volume":"81","author":"C Fraccaro","year":"2013","unstructured":"Fraccaro C, Napodano M, Tarantini G. Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective. Catheter Cardiovasc Interv. 2013;81(7):1217\u201323.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"4101_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jcin.2012.12.128","volume":"6","author":"RK Binder","year":"2013","unstructured":"Binder RK, Webb JG, Toggweiler S, Freeman M, Barbanti M, Willson AB, Alhassan D, Hague CJ, Wood DA, Leipsic J. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. JACC Cardiovasc Interv. 2013;6(5):462\u20138.","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"4101_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11886-021-01481-8","volume":"23","author":"A Sandhu","year":"2021","unstructured":"Sandhu A, Tzou WS. A disruptive technology: determining need for permanent pacing after TAVR. Curr Cardiol Rep. 2021;23(5):53.","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"4101_CR13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.amjcard.2015.12.009","volume":"117","author":"G Massoulli\u00e9","year":"2016","unstructured":"Massoulli\u00e9 G, Bordachar P, Ellenbogen KA, Souteyrand G, Jean F, Combaret N, Vorilhon C, Clerfond G, Farhat M, Ritter P, Citron B, Lusson JR, Motreff P, Ploux S, Eschalier R. New-Onset Left Bundle Branch Block Induced by Transcutaneous Aortic Valve Implantation. Am J Cardiol. 2016;117(5):867\u201373.","journal-title":"Am J Cardiol"},{"issue":"10","key":"4101_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4244\/EIJV9I10A195","volume":"9","author":"P Lange","year":"2014","unstructured":"Lange P, Greif M, Vogel A, Thaumann A, Helbig S, Schwarz F, Schmitz C, Becker C, D\u2019Anastasi M, Boekstegers P, Pohl T, Laubender RP, Steinbeck G, Kupatt C. Reduction of pacemaker implantation rates after CoreValve\u00ae implantation by moderate predilatation. EuroIntervention. 2014;9(10):1151\u20137.","journal-title":"EuroIntervention"},{"issue":"11","key":"4101_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/CIRCULATIONAHA.117.028352","volume":"136","author":"V Auffret","year":"2017","unstructured":"Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Philippon F, Rod\u00e9s-Cabau J. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation. 2017;136(11):1049\u201369.","journal-title":"Circulation"},{"issue":"10","key":"4101_CR16","doi-asserted-by":"publisher","first-page":"e020033","DOI":"10.1161\/JAHA.120.020033","volume":"10","author":"B El-Sabawi","year":"2021","unstructured":"El-Sabawi B, Welle GA, Cha YM, Espinosa RE, Gulati R, Sandhu GS, Greason KL, Crestanello JA, Friedman PA, Munger TM, Rihal CS, Eleid MF. Temporal incidence and predictors of high-Grade Atrioventricular Block after Transcatheter aortic valve replacement. J Am Heart Assoc. 2021;10(10):e020033.","journal-title":"J Am Heart Assoc"},{"issue":"21","key":"4101_CR17","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/j.jcin.2016.08.035","volume":"9","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Kozuma K, Hioki H, Kawashima H, Nara Y, Kataoka A, Nagura F, Nakashima M, Shirai S, Tada N, Araki M, Takagi K, Yamanaka F, Yamamoto M, Hayashida K. Pre-existing right Bundle Branch Block increases risk for death after transcatheter aortic valve replacement with a balloon-expandable valve. JACC Cardiovasc Interv. 2016;9(21):2210\u2013221.","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"4101_CR18","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/jcm10122719","volume":"10","author":"JM Ravaux","year":"2021","unstructured":"Ravaux JM, Mauro MD, Vernooy K, Mariani S, Ronco D, Simons J, Van\u2019t Hof AW, Veenstra L, Kats S, Maessen JG, Lorusso R. Impact of Bundle Branch Block on Permanent Pacemaker Implantation after Transcatheter aortic valve implantation: a Meta-analysis. J Clin Med. 2021;10(12):2719.","journal-title":"J Clin Med"},{"issue":"6","key":"4101_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.21037\/acs-2020-av-23","volume":"9","author":"S Chen","year":"2020","unstructured":"Chen S, Chau KH, Nazif TM. The incidence and impact of cardiac conduction disturbances after transcatheter aortic valve replacement. Ann Cardiothorac Surg. 2020;9(6):452\u201367.","journal-title":"Ann Cardiothorac Surg"},{"issue":"15","key":"4101_CR20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jcin.2017.06.012","volume":"10","author":"R Waksman","year":"2017","unstructured":"Waksman R, Steinvil A. Pre-transcatheter aortic valve replacement right bundle Branch Block: a bundle of trouble. JACC Cardiovasc Interv. 2017;10(15):1575\u20137.","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"4101_CR21","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.4244\/EIJV9I10A194","volume":"9","author":"P Houthuizen","year":"2014","unstructured":"Houthuizen P, van der Boon RM, Urena M, Van Mieghem N, Brueren GB, Poels TT, Van Garsse LA, Rod\u00e9s-Cabau J, Prinzen FW, de Jaegere P. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention. 2014;9(10):1142\u201350.","journal-title":"EuroIntervention"},{"issue":"24","key":"4101_CR22","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/eurheartj\/eht376","volume":"35","author":"TM Nazif","year":"2014","unstructured":"Nazif TM, Williams MR, Hahn RT, Kapadia S, Babaliaros V, Rod\u00e9s-Cabau J, Szeto WY, Jilaihawi H, Fearon WF, Dvir D, Dewey TM, Makkar RR, Xu K, Dizon JM, Smith CR, Leon MB, Kodali SK. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2014;35(24):1599\u2013607.","journal-title":"Eur Heart J"},{"issue":"2","key":"4101_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jcin.2013.08.015","volume":"7","author":"M Urena","year":"2014","unstructured":"Urena M, Webb JG, Cheema A, Serra V, Toggweiler S, Barbanti M, Cheung A, Ye J, Dumont E, DeLarochelli\u00e8re R, Doyle D, Al Lawati HA, Peterson M, Chisholm R, Igual A, Ribeiro HB, Nombela-Franco L, Philippon F, Garcia Del Blanco B, Rod\u00e9s-Cabau J. Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2014;7(2):128\u201336.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"4101_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jcin.2020.09.063","volume":"14","author":"Y Sammour","year":"2021","unstructured":"Sammour Y, Krishnaswamy A, Kumar A, Puri R, Tarakji KG, Bazarbashi N, Harb S, Griffin B, Svensson L, Wazni O, Kapadia SR. Incidence, predictors, and implications of permanent pacemaker requirement after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2021;14(2):115\u201334.","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"4101_CR25","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/j.jcin.2016.07.026","volume":"9","author":"OO Fadahunsi","year":"2016","unstructured":"Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of PermanentPacemaker Implantation following transcatheter aortic ValveReplacement: analysis from the U.S. Society of Thoracic Surgeons\/American College of Cardiology TVT Registry[J]. Jacc Cardiovasc Interventions. 2016;9(21):2189\u201399.","journal-title":"Jacc Cardiovasc Interventions"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04101-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T05:03:46Z","timestamp":1724475826000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04101-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4101"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04101-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"28 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and consent forms were approved by the Fujian Provincial Hospital Human Research Ethics Committee (approval number: K2023-06-015) and conformed to the ethical standards for medical research involving human subjects, as laid out in the 1964 Declaration of Helsinki and its later amendments. Any personal data contained in the manuscript was subject to the consent of the individual.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}